The diagnosis of CML requires clinical–pathological correlation and cannot be made solely based on the presence of BCR::ABL1, as this fusion gene has also been detected in healthy individuals [8,9]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.